LAUSANNE, Switzerland, Feb. 18, 2026 (GLOBE NEWSWIRE) -- NewBiologix S.A., a biotechnology company advancing recombinant ...

Swiss biotech NewBiologix, which is advancing recombinant adeno-associated virus (rAAV) production through next-generation clonal HEK293 cell line technology, today announced publication of ...

Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral vaccines based on its proprietary delivery platform, today announced that members of the management team ...

Epitogenx And Attomarker Sign Strategic Co-Development Agreement To Advance Precision Immunology Diagnostics. EINPresswire/ -- EpitogenX Ltd and Attomarker Ltd have announced the signing of a strategi ...

Indian-origin scientist Dr. Niju Narayanan, a Berkeley Lab researcher with global impact in biotechnology, passes away in ...

Collplant Holdings ( (CLGN) ) has issued an announcement.

Market News has followed the company’s development since its early scientific milestones, including when Kraig Labs stood before members of the media at a press conference held at the University of ...

Creative Diagnostics announces the release of a specialized portfolio of Antibiotic Residue Detection ELISA Kits. NEW ...

According to MarketsandMarketstm, the Elemental Analysis Market is projected to grow from about USD 4.54 billion in 2025 to USD 6.49 billion by 2030, at a CAGR of 7.4%. Browse 350 market data tables ...

The PDUFA date for Moderna's seasonal flu vaccine, is set for 5 August 2026, meaning it may reach the market for the 2026/2027 flu season.

According to MarketsandMarkets, the Elemental Analysis Market is projected to grow from about USD 4.54 billion in 2025 to USD 6.49 billion by ...